Japan Fusion Biopsy Market Size & Outlook, 2023-2030
Japan fusion biopsy market, 2018-2030 (US$M)
Related Markets
Japan fusion biopsy market highlights
- The Japan fusion biopsy market generated a revenue of USD 33.1 million in 2023 and is expected to reach USD 67.0 million by 2030.
- The Japan market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, transrectal was the largest revenue generating biopsy route in 2023.
- Transperineal is the most lucrative biopsy route segment registering the fastest growth during the forecast period.
Fusion biopsy market data book summary
| Market revenue in 2023 | USD 33.1 million |
| Market revenue in 2030 | USD 67.0 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Transrectal |
| Fastest growing segment | Transperineal |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transrectal, Transperineal |
| Key market players worldwide | Koninklijke Philips NV, Hitachi Ltd, Esaote, Eigen, MedCom, Koelis, Focal Healthcare, UC Care |
Other key industry trends
- In terms of revenue, Japan accounted for 5.3% of the global fusion biopsy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan fusion biopsy market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 67.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fusion Biopsy Market Scope
Fusion Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan fusion biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fusion biopsy market will help companies and investors design strategic landscapes.
Transrectal was the largest segment with a revenue share of 84.59% in 2023. Horizon Databook has segmented the Japan fusion biopsy market based on transrectal, transperineal covering the revenue growth of each sub-segment from 2018 to 2030.
Japan’s fusion biopsy market was valued at USD 23.4 million in 2020 and is expected to reach USD 56.6 million in 2028. More than 25% of the population in Japan is over the age of 65 years and faces an increased healthcare expenditure.
With the high health expenditure, Japan’s healthcare system is witnessing a transition, with more players expanding their service portfolio to include preventive and nursing care in disease management. The modern social security scheme is expected to create more opportunities for market growth.
Reasons to subscribe to Japan fusion biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan fusion biopsy market databook
-
Our clientele includes a mix of fusion biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan fusion biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Japan fusion biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan fusion biopsy market size, by biopsy route, 2018-2030 (US$M)
Japan Fusion Biopsy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
